Myr (MYRG) EBITDA (2010 - 2026)

Myr has disclosed EBITDA across 17 years of filings, most recently posting $45.5 million for Q1 2026.

• In Q1 2026, EBITDA rose 94.18% year-over-year to $45.5 million; the TTM figure through Mar 2026 stood at $145.0 million (up 409.4% YoY), while the FY2025 annual figure was $122.9 million, up 471.77% from the prior year.
• EBITDA grew to $45.5 million in Q1 2026, from $37.8 million in the prior quarter.
• Over the last five years, EBITDA for MYRG reached as high as $45.5 million in Q1 2026 and fell as low as -$16.4 million in Q2 2024.
• The 5-year median for EBITDA is $23.3 million (2023), against an average of $21.2 million.
• Annual changes were most pronounced in 2024 — EBITDA slumped 167.38% — and 2025, when it soared 297.3%.
• A 5-year view of EBITDA shows it stood at $25.9 million in 2022, then grew by 3.58% to $26.8 million in 2023, then plunged by 64.48% to $9.5 million in 2024, then soared by 297.3% to $37.8 million in 2025, then gained by 20.33% to $45.5 million in 2026.
• According to Business Quant data, EBITDA over the past three periods registered $45.5 million, $37.8 million, and $30.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.